Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on October 29, 2026

Oct. 29, 2026

Verano Celebrates Grand Opening of Newest Affiliated Dispensary, Zen Leaf Ephrata, Relocated to Prime New Location in Pennsylvania

Indeterminate GlobeNewswire

Oct. 29, 2026

Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics

Indeterminate GlobeNewswire

Oct. 29, 2026

GoldHaven Reaches 3,000 Metres Drilled at Magno, Advances High-Grade Silver-Lead-Zinc Targets in British Columbia's Cassiar District

Indeterminate GlobeNewswire

Oct. 29, 2026

SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference

Indeterminate GlobeNewswire

Oct. 29, 2026

Aventis Energy Confirms Strong Radioactivity up to 48,000 cps at Surface and Discovers New Showings at Saskatchewan’s Corvo Uranium Project

Indeterminate GlobeNewswire

Oct. 29, 2026

Midland Intersects Several New Gold-Bearing Intervals on Its Willbob Project in the Labrador Trough

Indeterminate GlobeNewswire

Oct. 29, 2026

Midland intersecte plusieurs nouveaux intervalles aurifères sur son projet Willbob dans la Fosse du Labrador

Indeterminate GlobeNewswire

Oct. 29, 2026

CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Oct. 29, 2026

Terra Clean Energy Completes Drill Pads and Trenching Ahead of Planned November Drilling at Marysvale Uranium Mines Project

Indeterminate GlobeNewswire

Oct. 29, 2026

Indivior Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Indeterminate GlobeNewswire

Oct. 29, 2026

Ligand Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences

Indeterminate GlobeNewswire

Oct. 29, 2026

Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Fortrea Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

Oct. 29, 2026

First Atlantic Begins Pit Excavation at the RPM Zone, Exposing Bedrock North of Current Drilling and Opening New Potential at Pipestone XL, as the Year-Round Exploration Access Road Connects the RPM Zone to Alloy Max and Super Gulp, Drilled Awaruite…

Indeterminate GlobeNewswire

Oct. 29, 2026

Oculis to Feature Privosegtor’s Neuroprotective Potential and Ongoing PIONEER Program at APOIS Congress and CNS Summit

Indeterminate GlobeNewswire

Oct. 29, 2026

Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)

Indeterminate GlobeNewswire

Oct. 29, 2026

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia

Indeterminate GlobeNewswire